Apple Watch Sales Paused Over Patent Dispute, But Key Feature Likely to Return by 2028
• US court ruled Apple infringed a Masimo patent on pulse oximetry tech used in Apple Watch
• This led to Apple pausing sales of certain Apple Watch models in the US without the blood oxygen measurement feature
• Masimo showed the feature could be re-enabled via jailbreaking, but this wasn't enough to uphold ban
• Apple has appealed the ruling; even if it loses, the patent expires in August 2028 allowing Apple to re-enable
• Therefore, Apple will at latest be able to re-enable blood oxygen measurement by August 2028 when patent expires